Literature DB >> 10959048

Matrix metalloproteinases: molecular aspects of their roles in tumour invasion and metastasis.

S Curran1, G I Murray.   

Abstract

The matrix metalloproteinases (MMPs) are a family of proteolytic enzymes, whose physiological functions include tissue remodelling and embryogenesis. The importance of this group of proteins in the processes of tumour invasion and metastasis is now widely acknowledged, and has led to the search for MMP inhibitors for use as anticancer treatments in a clinical setting. This review aims to bring the reader up-to-date with current research relating to MMPs, with particular emphasis on emerging mechanisms of regulation of these enzymes, and their interaction with cell adhesion molecules. The therapeutic inhibition of MMPs will also be discussed.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10959048     DOI: 10.1016/s0959-8049(00)00156-8

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN: 0959-8049            Impact factor:   9.162


  166 in total

1.  Analysis of mechanisms underlying BRMS1 suppression of metastasis.

Authors:  R S Samant; M J Seraj; M M Saunders; T S Sakamaki; L A Shevde; J F Harms; T O Leonard; S F Goldberg; L Budgeon; W J Meehan; C R Winter; N D Christensen; M F Verderame; H J Donahue; D R Welch
Journal:  Clin Exp Metastasis       Date:  2000       Impact factor: 5.150

2.  An extracellular matrix-associated zinc metalloprotease is required for dilauroyl phosphatidylethanolamine chemotactic excitation in Myxococcus xanthus.

Authors:  Daniel B Kearns; Pamela J Bonner; Daniel R Smith; Lawrence J Shimkets
Journal:  J Bacteriol       Date:  2002-03       Impact factor: 3.490

3.  XMRV accelerates cellular proliferation, transformational activity, and invasiveness of prostate cancer cells by downregulating p27(Kip1).

Authors:  Jui Pandhare-Dash; Chinmay K Mantri; Yuanying Gong; Zhenbang Chen; Chandravanu Dash
Journal:  Prostate       Date:  2011-09-19       Impact factor: 4.104

Review 4.  Structural basis of matrix metalloproteinases and tissue inhibitors of metalloproteinases.

Authors:  Klaus Maskos; Wolfram Bode
Journal:  Mol Biotechnol       Date:  2003-11       Impact factor: 2.695

5.  CD147 overexpression is a prognostic factor and a potential therapeutic target in bladder cancer.

Authors:  Yi-Jun Xue; Qiang Lu; Zhi-Xi Sun
Journal:  Med Oncol       Date:  2010-05-28       Impact factor: 3.064

6.  EMMPRIN/CD147 expression is associated with disease-free survival of patients with colorectal cancer.

Authors:  Shaojun Zhu; Dake Chu; Yang Zhang; Xuxia Wang; Li Gong; Xiujuan Han; Li Yao; Miao Lan; Yanhong Li; Wei Zhang
Journal:  Med Oncol       Date:  2013-02-07       Impact factor: 3.064

7.  Enhanced cell surface expression of matrix metalloproteinases and their inhibitors, and tumor-induced host response in progression of human gastric carcinoma.

Authors:  Shohei Koyama
Journal:  Dig Dis Sci       Date:  2004-10       Impact factor: 3.199

Review 8.  Invasion and metastasis of renal cell carcinoma.

Authors:  Shuji Mikami; Mototsugu Oya; Ryuichi Mizuno; Takeo Kosaka; Ken-ichi Katsube; Yasunori Okada
Journal:  Med Mol Morphol       Date:  2013-11-09       Impact factor: 2.309

Review 9.  Revisiting the hallmarks of cancer.

Authors:  Yousef Ahmed Fouad; Carmen Aanei
Journal:  Am J Cancer Res       Date:  2017-05-01       Impact factor: 6.166

10.  Expression of matrix metalloproteinases-2 and -9 and RECK during alveolar bone regeneration in rat.

Authors:  Thais Accorsi-Mendonça; Katiúcia Batista da Silva Paiva; Willian Fernando Zambuzzi; Tânia Mary Cestari; Vanessa Soares Lara; Mari Cleide Sogayar; Rumio Taga; José Mauro Granjeiro
Journal:  J Mol Histol       Date:  2007-11-07       Impact factor: 2.611

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.